M3, Inc. (MTHRY)
OTCMKTS · Delayed Price · Currency is USD
7.96
+0.07 (0.89%)
Sep 12, 2025, 3:58 PM EDT
M3, Inc. Market Cap
M3, Inc. has a market cap or net worth of $10.87 billion as of September 15, 2025. Its market cap has increased by 67.63% in one year.
Market Cap
10.87B
Enterprise Value
10.54B
Revenue
2.13B
Ranking
n/a
PE Ratio
38.00
Stock Price
$7.96
Market Cap Chart
Since September 16, 2004, M3, Inc.'s market cap has increased from 488.38M to 10.87B, an increase of 2,125.41%. That is a compound annual growth rate of 15.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 10.87B | 80.07% |
| Dec 30, 2024 | 6.04B | -46.29% |
| Dec 29, 2023 | 11.24B | -38.99% |
| Dec 30, 2022 | 18.42B | -46.06% |
| Dec 30, 2021 | 34.15B | -46.65% |
| Dec 30, 2020 | 64.01B | 210.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |